Evidence map›Paper›PMID 42789196›Full record

ArticleAnnals of surgical oncology2026

Delta

Rui Zuo, Lu Xu, Tingting Xu, Wenbo Li, Zhu Xia, Ke Cheng, Guangfu Liu, Yue Chen, Zhengjie Wang, Hua Pang

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rui Zuo *Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lu Xu *Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Tingting Xu *Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Wenbo LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhu XiaDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ke ChengDepartment of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Guangfu LiuDepartment of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Yue ChenDepartment of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. chenyue5523@126.com.
Zhengjie WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. bkzg1234@163.com.
Hua PangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Phua1973@163.com.

Funding

Chongqing Technology Bureau CSTB2024TIAD-STX0048the National Natural Science Foundation of China 82472019
6 · The paper itself

Abstract

objectiveUnilateral primary aldosteronism (PA) can be cured through adrenalectomy. We developed a

methodsA total of 359 patients with PA who underwent dual-time-phase (10 min and 40 min)

resultsAmong the eight radiomics models, the XGBoost model achieved the best classification performance and was selected for the final model. Among the three PET models, the delta PET model yielded the highest area under the curve in the training set (0.875; 95% confidence interval [CI] 0.814-0.935), validation set (0.861; 95% CI 0.754-0.968), and external test set (0.860; 95% CI 0.773-0.946). The combined clinical-radiomics model showed superior area under the curve values: 0.926 (95% CI 0.891-0.962) in training, 0.909 (95% CI 0.836-0.983) in validation, and 0.919 (95% CI 0.855-0.982) in external testing. The combined model outperformed the PET/CT model across all datasets and demonstrated good calibration and clinical utility.

conclusionThe model incorporating delta

Indexed as

68Ga-PentixaforAdrenalectomyMachine learningPET/CTPrimary aldosteronismRadiomics

Identifiers

PMID42789196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.